Life Sciences & Molecular Therapeutics (LSMT) pioneers targeted genetic interventions and precision synthetic gene circuits. By combining AI-driven protein folding models with ultra-stable lipid nanoparticle vectors, we eradicate complex cellular disease at its root code.
Engineering proprietary engineered nucleases that correct single-nucleotide polymorphisms in vivo with absolute single-base precision, avoiding chromosomal toxicity.
Developing circular RNA (circRNA) architectures that dramatically extend protein translation half-life inside target tissues for sustained therapeutic efficacy.
Utilizing deep neural networks trained on millions of molecular interactions to design entirely de novo proteins that neutralize previously undruggable oncogenic targets.